trending Market Intelligence /marketintelligence/en/news-insights/trending/E9QVjV5Dd0gF5fIypWJwSw2 content esgSubNav
In This List

NextCell Pharma CFO steps down; replacement named

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


NextCell Pharma CFO steps down; replacement named

NextCell Pharma AB said Leo Groenewegen will step down as its CFO to serve in the newly created position of business development manager.

The Swedish company said Sofia Fredrikson will become the new CFO starting Dec. 5. Fredrikson, who has been working at NextCell since November, was previously employed at BDO AB and KPMG AB.

NextCell Pharma develops ProTrans, a drug comprising stem cells for treating autoimmune and inflammatory diseases as well as for use in kidney transplants.